Reuters logo
BRIEF-Argos Therapeutics Reports Highlights from Investor Day in New York City
December 7, 2016 / 10:16 PM / a year ago

BRIEF-Argos Therapeutics Reports Highlights from Investor Day in New York City

Dec 7 (Reuters) - Argos Therapeutics Inc

* Argos Therapeutics - Expects to invest an estimated $4-5 million for initial build-out and equipping of facility, additional $1-1.5 million in next 1-2 years to complete subsequent expansion

* Argos Therapeutics - Announced planned implementation of a two-stage manufacturing strategy for rocapuldencel-T and other therapies developed based on Arcelis platform Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below